💊
Cinryze
C1 inhibitor (human)
Angio-œdèmes héréditaires
✅ Autorisé
✅
Aucune alerte active
Ce médicament ne fait l'objet ni de pénuries en cours, ni de lettres de sécurité, ni de rappels.
À quoi ça sert
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
⚠️ Sécurité des patients
No
📚 Alertes passées (2)
Page officielle de l'EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/cinryze